共 34 条
- [1] Lacroix A(2015)Cushing’s syndrome Lancet 386 913-927
- [2] Santos A(2015)Quality of life in Cushing’s syndrome Pituitary 18 195-200
- [3] Ferrau F(2015)Metabolic comorbidities in Cushing’s syndrome Eur. J. Endocrinol. 173 M133-M157
- [4] Korbonits M(2021)Consensus on diagnosis and management of Cushing’s disease: a guideline update Lancet Diabetes Endocrinol. 9 847-875
- [5] Fleseriu M(2003)Discriminatory Value of the Low-Dose Dexamethasone Suppression Test in Establishing the Diagnosis and Differential Diagnosis of Cushing’s Syndrome J. Clin. Endocrinol. Metab. 88 5299-5306
- [6] Isidori AM(1986)The ovine corticotropin-releasing hormone stimulation test and the dexamethasone suppression test in the differential diagnosis of Cushing’s syndrome Ann. Intern. Med. 105 862-867
- [7] Nieman LK(2009)Evaluation of Diagnostic Tests for ACTH-Dependent Cushing’s Syndrome Endocr. J. 56 469-476
- [8] Suda T(2008)he role of non-invasive dynamic tests in the diagnosis of Cushing’s syndrome J. Endocrinol. Investig. 31 1008-1013
- [9] Vilar L(1996)Plasma corticotropin and cortisol responses to ovine corticotropin-releasing hormone (CRH), arginine vasopressin (AVP), CRH plus AVP, and CRH plus metyrapone in patients with Cushing’s disease J. Clin. Endocrinol. Metab. 81 2934-2941
- [10] Dickstein G(2021)Development and validation of a novel index for the differential diagnosis of corticotropin‐dependent Cushing syndrome Pituitary 24 507-516